EN DE
Watch ACROMETA GROUP LIMITED for free: we tell you when fair value or trend changes.
Data-driven stock valuation

ACROMETA GROUP LIMITED (43F) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of ACROMETA GROUP LIMITED stock S$0.01, price S$0.01, upside +4.4%, quality 44 out of 100. Rating: fairly valued. Calculated from audited financials with 6 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials SG · ISIN SG1CH1000006

AG ACROMETA GROUP LIMITED logo Thin data Nov 13, 2026

ACROMETA GROUP LIMITED

43F · SG

The stock is already about fairly priced, weak company and falling price: meets none of the 3 rules.

Get notified free when this changes
Low debt 
Generates free cash flow 
Fair value 0.0094 SGD · Fairly valued 
Quality 44/100 
Revenue last quarter 13% below a year ago. 
Changed on Oct 25: S$0.0118 → S$0.0094 
Falling price (downtrend) 
Weak Growth (revenue 5y −28.8 %/yr in SGD) 
Loss-making · -107.7% net margin (TTM) 
Trails peers (3/11) 
Narrow moat 6/100 · thin data
Thin data 
⚠ Dilution
Watch ACROMETA GROUP LIMITED for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

0.0667 SGD 0.0090 SGD Fair Value 0.0094 SGD Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 13, 2026.

How to read this chart

60‑month range 0.0090 SGD – 0.0667 SGD · fair‑value band 0.0085 SGD – 0.0103 SGD · the 0.0090 SGD price screens below the 0.0094 SGD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 13, 2026.

Follow ACROMETA GROUP in your weekly email

Every Wednesday you see whether ACROMETA GROUP is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

AcroMeta Group Limited, together with its subsidiaries, provides engineering services in the field of controlled environments in Singapore. The company operates through Maintenance and Co-working Laboratory Space segments.

Show moreShow less

The Maintenance segment offers installation and maintenance services for controlled environments and supporting infrastructure. The Co-working Laboratory Space segment operates and manages co-working laboratory space for research and technology.

It also engages in the import and distribution of laboratory furniture and accessories; and provision of maintenance and installation services for air-conditioning and mechanical ventilation systems.

In addition, the company manufactures and wholesales non-metallic mineral products; and rents fitted laboratory spaces for research and technology.

It serves hospitals, medical centers, government agencies, research and development companies, agencies, multinational corporations, and tertiary educational institutions, as well as pharmaceutical, semiconductor manufacturing, and engineering companies.

The company was formerly known as ACROMEC Limited and changed its name to AcroMeta Group Limited in February 2022. AcroMeta Group Limited was founded in 1996 and is based in Singapore.

Stock analysis

ACROMETA GROUP LIMITED (43F) currently trades at 0.0090 SGD, while our model-based Fair Value estimate is 0.0094 SGD, so the stock looks roughly fairly valued today (gap 4.2%).

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of 0.0250 SGD per share, and 6 of the 6 models we run sit above the 0.0090 SGD price.

Bear case: the Multiples group reads lowest at 0.0100 SGD, and 0 of the 6 models stay below the price. Data coverage for this calculation is low.

Scenario range: 0.0085 SGD (bear) to 0.0103 SGD (bull), the price of 0.0090 SGD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 44/100 (below-average quality), in the Industrials sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

ACROMETA GROUP LIMITED reported revenue of 4.2M SGD in FY2025 versus 29.1M SGD in FY2021, a compound −38.2%/yr. Reported net income was −4.3M SGD in FY2025.

Key figures

Market cap 4.7M SGD (≈ $3.6M) Micro · P/S ratio 1.32 · EPS (TTM) −0.0100 SGD · Net margin −108% · Return on equity −130% · Return on assets (EBIT) −20.9% (5-year average) · Operating margin −92.1% · Revenue (TTM) 4.0M SGD.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 6 out of 100 (low confidence).

What moves the price

The share trades about 67% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −31% fair-value upside, at 4%, 43F screens cheaper than that median.

Fair Value models

Bear 0.0085 SGD Fair Value 0.0094 SGD Bull 0.0103 SGD
Price 0.0090 SGD · Upside +4.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 0.0200 SGD 0.0300 SGD 0.0400 SGD 81
Growth DCF 0.0200 SGD 0.0300 SGD 0.0400 SGD 79
5Y Revenue Exit 0.0100 SGD 0.0200 SGD 0.0300 SGD 71
All 6 models by family
DCF Models
FCF DCF 0.0200 SGD 0.0300 SGD 0.0400 SGD 81
5Y Revenue Exit 0.0100 SGD 0.0200 SGD 0.0300 SGD 71
10Y Revenue Exit 0.0100 SGD 0.0200 SGD 0.0300 SGD 65
Multiples
EV/Revenue 0.0100 SGD 0.0100 SGD 0.0200 SGD 51
Growth DCF
Growth DCF 0.0200 SGD 0.0300 SGD 0.0400 SGD 79
Rev-Margin DCF 0.0100 SGD 0.0200 SGD 0.0300 SGD 71

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 44/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 19
How much profit the company makes from its sales and capital
Quality Growth 38
Are margins and returns getting better?
Cashflow 67
Do the profits arrive as real cash?
Financial strength 71
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 23/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−25.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−59.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−28.8%
Start year 2020 (pandemic). Over 10 years: −19.1% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−14.3%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−5.6% (2020) → −104.0% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

Little optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
less than -40 %
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.

Watch 43F, get fair value alerts →

Compare ACROMETA GROUP LIMITED with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Engineering & Construction · 829 stocks

Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 44 · Below median
Fair Value upside +4.4% · Above median
Profitability
Return on assets −76.2% · Bottom 25%
Net margin (12 months) −107.7% · Bottom 25%
Operating margin (12 months) −92.1% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −13.2% · Bottom 25%
Balance sheet
Debt / equity 0.23× · Above median

Valuation Multiplesvs Engineering & Construction median · lower = cheaper

P/B 1.29× · Cheaper than median
P/S (12 months) 1.19× · Pricier than median
Price / free cash flow (fiscal year) 9.9× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)39 · sector 33
FUTURE (revenue growth)0 · sector 23
PAST (return on equity)0 · sector 26
HEALTH (low debt)88 · sector 94
DIVIDEND (yield)0 · sector 42

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Engineering & Construction stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Vinci SA DG €115.25 €186.68 +62% vs 43F
Bouygues SA EN €44.66 €65.77 +47% vs 43F
Comfort Systems USA, Inc FIX $1,113 $1,122 +1% vs 43F
EMCOR Group EME $659.36 $524.14 −21% vs 43F
ACS, Actividades de Construcción y Servicios, S.A ACS €91.05 €62.38 −31% vs 43F
Samsung C&T Corporation 028260 276,500 KRW 159,702 KRW −42% vs 43F
Larsen & Toubro Limited LT ₹4,140 ₹2,302 −44% vs 43F
HOCHTIEF Aktiengesellschaft HOT €371.80 €203.86 −45% vs 43F
APi Group APG $43.47 $19.20 −56% vs 43F
Quanta Services, Inc PWR $602.01 $162.41 −73% vs 43F

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

ACROMETA GROUP LIMITED: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "ACROMETA GROUP LIMITED Fair Value". https://www.fairvalue-calculator.com/stock/43F

Frequently asked questions

Is ACROMETA GROUP LIMITED (43F) overvalued or undervalued?
As of Nov 13, 2026, our model estimates a fair value of 0.0094 SGD versus a price of 0.0090 SGD, about +4% upside (fairly valued).
What is the fair value of 43F?
Our model-based fair value for ACROMETA GROUP LIMITED is 0.0094 SGD (as of Nov 13, 2026), built from audited fundamentals. The current price: 0.0090 SGD.
What is the quality score of 43F?
ACROMETA GROUP LIMITED has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for ACROMETA GROUP LIMITED (43F)?
Our model-based price target is the fair value of 0.0094 SGD (as of Nov 13, 2026) from 6 valuation models. Cautious scenario 0.0085 SGD, optimistic scenario 0.0103 SGD. It is a calculation from audited fundamentals, not an analyst target.
What is the ACROMETA GROUP LIMITED stock forecast for 2026?
Our models put fair value at 0.0094 SGD, about +4% upside versus a price of 0.0090 SGD (fairly valued). Cautious scenario 0.0085 SGD, optimistic scenario 0.0103 SGD. The calculation is refreshed regularly with new filings.
What is the revenue of ACROMETA GROUP LIMITED (43F)?
ACROMETA GROUP LIMITED reported trailing-twelve-month revenue of about 4.0M SGD (latest available figure, as of Nov 13, 2026).
What growth is priced into ACROMETA GROUP LIMITED (43F)?
Today's price is already fair in a discounted-cash-flow model if free cash flow at ACROMETA GROUP LIMITED shrinks by more than 40 % per year for five years (discount rate 8.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue fell 28.8 % per year. As of Nov 13, 2026.
What discount rate (WACC) does the fair value of 43F use?
Our models discount ACROMETA GROUP LIMITED at 8.3 %: a base by market capitalisation (nano), damped by beta 0.16, country premium for Singapore. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For ACROMETA GROUP LIMITED that is less than minus 40 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (8.3 %) and the same formula as our fair value.
How much growth has ACROMETA GROUP LIMITED (43F) delivered so far?
Over the past 5 years revenue at ACROMETA GROUP LIMITED shrank 28.8 % a year. The price currently implies free-cash-flow growth of less than minus 40 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of ACROMETA GROUP LIMITED (43F) growing?
The median revenue growth in the sector is +8.2 % a year. That is the yardstick for the growth priced into ACROMETA GROUP LIMITED (less than minus 40 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of ACROMETA GROUP LIMITED (43F)?
The free-cash-flow yield on the price is 13.49 %: that much free cash flow ACROMETA GROUP LIMITED produces per unit of market value. When it exceeds the discount rate of our models (8.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of ACROMETA GROUP LIMITED (43F)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For ACROMETA GROUP LIMITED it is 0.0094 SGD per share (as of Nov 13, 2026), against a price of 0.0090 SGD. It is the blended result of 6 valuation models in 3 families (DCF Models, Multiples, Growth DCF).
Is ACROMETA GROUP LIMITED stock overvalued or undervalued in 2026?
As of Nov 13, 2026, 43F trades below its calculated fair value: price 0.0090 SGD, fair value 0.0094 SGD, a gap of about +4% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 43F?
No. The price is what the market pays today (0.0090 SGD); the fair value is what the company's own numbers justify (0.0094 SGD). For ACROMETA GROUP LIMITED the two are 0.0004 SGD per share apart. That gap is exactly why we show both numbers side by side.
How much is ACROMETA GROUP LIMITED worth?
The market values ACROMETA GROUP LIMITED at about 4.7M SGD (market capitalisation, as of Nov 13, 2026). Per share that is 0.0090 SGD; our models calculate a fair value of 0.0094 SGD per share.
What do the bullish and bearish scenarios say about 43F?
Our models span a range for ACROMETA GROUP LIMITED: cautious scenario 0.0085 SGD, base 0.0094 SGD, optimistic 0.0103 SGD per share (as of Nov 13, 2026, price 0.0090 SGD). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of ACROMETA GROUP LIMITED (43F)?
Balance-sheet figures for ACROMETA GROUP LIMITED (as of Nov 13, 2026): return on equity −129.7%, debt of 0.23 per unit of equity. They feed the Quality Score of 44/100, which measures business quality independently of the share price.
How far is 43F from its 52-week high?
ACROMETA GROUP LIMITED trades at 0.0090 SGD, about 67% below its 52-week high of 0.0270 SGD and at the low of 0.0090 SGD (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of 0.0094 SGD is for.
Which stocks are comparable to ACROMETA GROUP LIMITED?
From the same area (Industrials) we also value Quanta Services, Inc, Vinci SA, Larsen & Toubro Limited, Comfort Systems USA, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is ACROMETA GROUP LIMITED stock attractive at the current price?
The data as of Nov 13, 2026: price 0.0090 SGD, calculated fair value 0.0094 SGD (+4%), Quality Score 44/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 43F calculated?
We run ACROMETA GROUP LIMITED through 6 models from 3 families: DCF Models, Multiples, Growth DCF. Every model gets the same audited fundamentals; the fair value of 0.0094 SGD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. ACROMETA GROUP LIMITED currently trades 4% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of ACROMETA GROUP LIMITED (43F)?
The closing price on Nov 16, 2026 was 0.0090 SGD. Our model-based fair value is 0.0094 SGD, about +4% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with ACROMETA GROUP LIMITED right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of ACROMETA GROUP LIMITED

How large is the market capitalisation of ACROMETA GROUP LIMITED (43F)?
The market capitalisation of ACROMETA GROUP LIMITED is 4.7M SGD (≈ $3.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of ACROMETA GROUP LIMITED (43F)?
The price-to-sales ratio of ACROMETA GROUP LIMITED is 1.32 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of ACROMETA GROUP LIMITED (43F)?
Earnings per share at ACROMETA GROUP LIMITED are −0.0100 SGD. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of ACROMETA GROUP LIMITED (43F)?
The net margin of ACROMETA GROUP LIMITED is −108% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of ACROMETA GROUP LIMITED (43F)?
The return on equity (ROE) of ACROMETA GROUP LIMITED is −130% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of ACROMETA GROUP LIMITED (43F)?
On an EBIT basis the return on assets of ACROMETA GROUP LIMITED is −20.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of ACROMETA GROUP LIMITED (43F)?
The operating margin of ACROMETA GROUP LIMITED is −92.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at ACROMETA GROUP LIMITED (43F)?
Revenue at ACROMETA GROUP LIMITED is down 13.2% versus a year earlier (3y avg −59.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at ACROMETA GROUP LIMITED (43F)?
Earnings per share at ACROMETA GROUP LIMITED are down 13.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does ACROMETA GROUP LIMITED (43F) carry?
The net debt of ACROMETA GROUP LIMITED is 169K SGD (fiscal year 2024, ≈ 0.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch ACROMETA GROUP LIMITED in the live analysis

One click puts ACROMETA GROUP LIMITED on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.